Confounding Issues in Estimation of Patient-Specific Pharmacokinetic Parameters and Dosage Individualization of Aminoglycosides

被引:2
|
作者
Mehvar, Reza [1 ]
机构
[1] Texas Tech Univ, Sch Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Amarillo, TX 79106 USA
来源
CURRENT CLINICAL PHARMACOLOGY | 2012年 / 7卷 / 01期
关键词
Aminoglycoside dosing; clearance; clinical pharmacokinetics; elimination rate constant; intermittent intravenous infusion; patient-specific pharmacokinetics; peak and trough; volume of distribution;
D O I
10.2174/157488412799218833
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aminoglycoside antibiotics are usually administered by multiple short intravenous infusions at fixed intervals. Today, equations reported 35 years ago by Sawchuk and Zaske are still the cornerstone of methods used for determination of patient-specific pharmacokinetic parameters of aminoglycosides and individualization of drug dosage regimens in many clinical settings. Additionally, these methods are included in many clinical pharmacology curricula in pharmacy and other related fields. However, there are a few issues with regard to the application and/or modification of this method in clinical settings, which may result in some confusion among novice clinicians. For example, serum samples collected from different intervals at steady state, instead of samples obtained during the same interval, require special manipulation of sampling time before they can be used for estimation of pharmacokinetic parameters. Furthermore, there are various ways that the original equations are modified or simplified, which can result in some degree of error in the estimates of pharmacokinetic parameters and ensuing dosage regimen calculations. Simulation data presented here indicate that in some cases, these errors may be substantial, depending on the length of short infusion, half life of the drug, and the dosage interval. For instance, using equations developed for intravenous bolus mode of administration, ignoring the short infusion, may result in >= 25% error for a typical patient and dosing scenario. Although experts may use modified equations, understanding their error ramifications, these modifications may be confusing to the novice clinician. Therefore, it is recommended that exact equations developed specifically for multiple intravenous infusions be used without any modification, particularly in settings where clinicians are being trained.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [1] USE OF AMINOGLYCOSIDES IN CRITICALLY ILL PATIENTS - INDIVIDUALIZATION OF DOSAGE USING BAYESIAN STATISTICS AND PHARMACOKINETIC PRINCIPLES
    BOTTGER, HC
    OELLERICH, M
    SYBRECHT, GW
    THERAPEUTIC DRUG MONITORING, 1988, 10 (03) : 280 - 286
  • [3] Patient-specific factors predictive of warfarin dosage requirements
    Absher, RK
    Moore, ME
    Parker, MH
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (10) : 1512 - 1517
  • [4] PHARMACOKINETICS OF SULFALEN (KELFIZIN) .3. USE OF PHARMACOKINETIC PARAMETERS FOR INDIVIDUALIZATION OF SULFALEN DOSAGE SCHEDULE
    KHOLODOV, LE
    LILYIN, ET
    KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1978, 12 (03): : 22 - 28
  • [5] Comment: patient-specific factors predictive of warfarin dosage requirements
    Lindh, JD
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (03) : 454 - 454
  • [6] Determining Patient-Specific Dosage Scheme Using Integer Programming
    Hellemo, Lars
    Brun, Vegard Heimly
    XV MEDITERRANEAN CONFERENCE ON MEDICAL AND BIOLOGICAL ENGINEERING AND COMPUTING - MEDICON 2019, 2020, 76 : 1264 - 1269
  • [7] Patient-Specific Pose Estimation in Clinical Environments
    Chen, Kenny
    Gabriel, Paolo
    Alasfour, Abdulwahab
    Gong, Chenghao
    Doyle, Werner K.
    Devinsky, Orrin
    Friedman, Daniel
    Dugan, Patricia
    Melloni, Lucia
    Thesen, Thomas
    Gonda, David
    Sattar, Shifteh
    Wang, Sonya
    Gilja, Vikash
    IEEE JOURNAL OF TRANSLATIONAL ENGINEERING IN HEALTH AND MEDICINE, 2018, 6
  • [8] Patient-Specific Debye Parameters for Human Blood
    Santorelli, Adam
    O'Halloran, Martin
    2019 41ST ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2019, : 238 - 242
  • [9] Patient Activity After TKA Depends on Patient-specific Parameters
    Luetzner, Cornelia
    Kirschner, Stephan
    Luetzner, Joerg
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2014, 472 (12) : 3933 - 3940
  • [10] Patient-specific dose estimation for pediatric chest CT
    Li, Xiang
    Samei, Ehsan
    Segars, W. Paul
    Sturgeon, Gregory M.
    Colsher, James G.
    Frush, Donald P.
    MEDICAL PHYSICS, 2008, 35 (12) : 5821 - 5828